Company
United StatesPublic company, NYSE: BDXBecton Dickinson And Company (NYSE: BDX), Columbus, NE – FDA Inspections
Inspection records and compliance data for Becton Dickinson And Company in Columbus, Nebraska. 5 FDA inspections on record, 1 Form 483, last inspected May 12, 2017. Publicly traded as NYSE: BDX.
Company Profile
This profile covers Becton Dickinson And Company based in Columbus, Nebraska, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 4
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected August 27, 2009. Last inspected May 12, 2017.
Most cited issue areas
- Documentation1 inspection
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 12, 2017 | VAI | Medical Devices & Rad Health · Compliance: Devices | 1012404 |
| August 11, 2016 | VAI | Medical Devices & Rad Health · Compliance: Devices | 985379 |
| September 11, 2013 | VAI | Medical Devices & Rad Health · Compliance: Devices | 847638 |
| April 21, 2011 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 723716 |
| August 27, 2009 | VAI | Medical Devices & Rad Health · Compliance: Devices | 607365 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Becton Dickinson And Company
Stock ticker
BDX
Exchange
NYSE
Share price
$215.73
Market cap
$58.8B
Price as of
November 13, 2026
FEI Number
1911916
Address
2153 12th Ave, Columbus, Nebraska 68601, United States
Country
United States
ID: ae6eec0c-53a8-40d9-9a16-a0ab8614c348